Prevention of osteoporosis in women treated for hereditary breast and ovarian carcinoma: a need that is overlooked

Cancer. 1998 Sep 1;83(5):830-4. doi: 10.1002/(sici)1097-0142(19980901)83:5<830::aid-cncr2>3.0.co;2-m.
No abstract available

MeSH terms

  • Adult
  • Alendronate / therapeutic use
  • Breast Neoplasms / drug therapy*
  • Calcitonin / therapeutic use
  • Diet
  • Diphosphonates / therapeutic use
  • Exercise Therapy
  • Female
  • Humans
  • Life Style
  • Neoplastic Syndromes, Hereditary / drug therapy*
  • Osteoporosis / chemically induced
  • Osteoporosis / prevention & control*
  • Ovarian Neoplasms / drug therapy*

Substances

  • Diphosphonates
  • Calcitonin
  • Alendronate